Stock comparison
Aveanna Healthcare Holdings
IDEXX Laboratories
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
AVAH
Aveanna Healthcare Holdings
Market cap
$1.6B
Sector
Healthcare
IDXX
IDEXX Laboratories
Market cap
$44.12B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | AVAH | IDXX | Winner |
|---|---|---|---|
| Warren Buffett | 38D | 75B | IDXX |
| Benjamin Graham | 57D | 80A | IDXX |
| Philip Fisher | 35D | 75B | IDXX |
| Peter Lynch | 69B | 71B | IDXX |
| Joel Greenblatt | 46D | 83C | IDXX |
| Charlie Munger | 42D | 87A | IDXX |
| Terry Smith | 31F | 84A | IDXX |
Side-by-side metrics
| Metric | AVAH | IDXX |
|---|---|---|
| Market cap | $1.6B | $44.12B |
| P/E (TTM) | 6.3x | 39.0x |
| EV/EBIT | 11.3x | 31.6x |
| ROIC (TTM) | 15.86% | 40.66% |
| Gross margin | 32.67% | 62.05% |
| Net margin | 10.37% | 24.63% |
| Revenue CAGR 5y | 9.73% | 7.56% |
| EPS CAGR 5y | - | 10.79% |
| Debt / Equity | 6.3x | 0.7x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
AVAH leads on
- P/E (TTM)6.3xvs 39.0x+84%
- EV/EBIT11.3xvs 31.6x+64%
- Revenue CAGR 5y9.73%vs 7.56%+22%
IDXX leads on
- Market cap$44.12Bvs $1.6B+96%
- Debt / Equity0.7xvs 6.3x+89%
- ROIC (TTM)40.66%vs 15.86%+61%
- Net margin24.63%vs 10.37%+58%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.